Avadel Pharmaceuticals plc total revenue, net income and dynamics of changes in US dollar today
Avadel Pharmaceuticals plc net revenue for today is 0 $. Avadel Pharmaceuticals plc net income is now -13 445 000 $. The dynamics of Avadel Pharmaceuticals plc net income went down. The change was -2 167 000 $. Graph of finance company Avadel Pharmaceuticals plc. The financial graph of Avadel Pharmaceuticals plc displays the online status: net income, net revenue, total assets. All information on Avadel Pharmaceuticals plc total revenue on this chart is created in the form of yellow bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
The latest dates of Avadel Pharmaceuticals plc financial statements available online: 30/06/2018, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of Avadel Pharmaceuticals plc is available online for such a date - 31/03/2021. Operating income Avadel Pharmaceuticals plc is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Avadel Pharmaceuticals plc is -14 864 000 $
Avadel Pharmaceuticals plc quarterly report dates
Net income Avadel Pharmaceuticals plc is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Avadel Pharmaceuticals plc is -13 445 000 $ Current assets Avadel Pharmaceuticals plc is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Avadel Pharmaceuticals plc is 242 314 000 $ Total assets Avadel Pharmaceuticals plc refers to the total amount of assets owned by a person or entity. Total assets Avadel Pharmaceuticals plc is 292 941 000 $
Current cash Avadel Pharmaceuticals plc - the sum of all of the cash a company has on the date of report. Current cash Avadel Pharmaceuticals plc is 59 172 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-
-
-
6 806 000 $
3 867 000 $
3 640 000 $
5 842 000 $
49 871 000 $
5 304 000 $
13 828 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
3 285 000 $
10 362 000 $
13 914 000 $
10 595 000 $
-28 951 000 $
14 522 000 $
15 402 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
-
-
10 091 000 $
14 229 000 $
17 554 000 $
16 437 000 $
20 920 000 $
19 826 000 $
29 230 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
14 229 000 $
17 554 000 $
16 437 000 $
20 920 000 $
19 826 000 $
29 230 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-14 864 000 $
-14 260 000 $
-13 992 000 $
-4 549 000 $
-1 654 000 $
-3 322 000 $
-4 805 000 $
-14 281 000 $
-21 145 000 $
-15 624 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-13 445 000 $
-11 278 000 $
-11 703 000 $
30 874 000 $
-8 864 000 $
-8 605 000 $
-13 018 000 $
-63 859 000 $
-15 771 000 $
-3 438 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
3 852 000 $
5 286 000 $
5 569 000 $
4 057 000 $
7 539 000 $
7 539 000 $
7 539 000 $
39 329 000 $
6 086 000 $
6 086 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
14 864 000 $
14 260 000 $
13 992 000 $
14 640 000 $
15 883 000 $
20 876 000 $
21 242 000 $
35 201 000 $
40 971 000 $
44 854 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
242 314 000 $
263 454 000 $
281 688 000 $
277 019 000 $
88 602 000 $
97 200 000 $
102 437 000 $
168 269 000 $
147 876 000 $
174 976 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
292 941 000 $
311 637 000 $
327 635 000 $
341 401 000 $
155 888 000 $
165 709 000 $
173 622 000 $
190 300 000 $
269 006 000 $
295 236 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
59 172 000 $
71 722 000 $
83 109 000 $
102 174 000 $
12 867 000 $
17 111 000 $
9 630 000 $
9 325 000 $
17 837 000 $
12 477 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
31 763 000 $
33 580 000 $
31 358 000 $
28 408 000 $
47 019 000 $
51 613 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
182 851 000 $
183 486 000 $
183 204 000 $
187 520 000 $
203 264 000 $
216 690 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
117.30 %
110.73 %
105.52 %
98.54 %
75.56 %
73.40 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
136 499 000 $
162 261 000 $
171 195 000 $
182 120 000 $
-26 963 000 $
-17 777 000 $
-9 582 000 $
2 780 000 $
65 742 000 $
78 546 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-7 419 000 $
-1 447 000 $
-21 206 000 $
-24 526 000 $
-20 248 000 $
-19 934 000 $
Last revenue report of Avadel Pharmaceuticals plc was 31/03/2021. According to last financial report total revenue in Avadel Pharmaceuticals plc was 0 US dollar and changed by -100% since last year. Net income in Avadel Pharmaceuticals plc was -13 445 000 $ in last quartal, net income changes to 0%.
